Skip to content

Efficacy of SASI Bypass in Super Obese Patients

Assessment of the Efficacy of SASI Bypass in Super Obese Patients With BMI> 50 Kg/m2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04037670
Enrollment
20
Registered
2019-07-30
Start date
2017-07-01
Completion date
2019-07-20
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

Although previous studies investigated weight loss and improvement in comorbidities after SASI bypass, patients included in these studies had a BMI less than 50 Kg/m2. Therefore, the aim of the present study was to investigate the outcome of SASI bypass in patients with super obesity to assess the success of this novel bariatric procedure in this challenging group of patients in regards weight loss and improvement in associated comorbid conditions at 12 months postoperatively.

Interventions

PROCEDURESASI bypass

Sleeve gastrectomy with single loop anastomosis between gastric antrum and ileum, 3 meters away from ileocecal junction

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients included to the present study were adult patients of both genders aging between 18 and 65 years with primary morbid obesity with BMI ≥50 kg/m2 with or without obesity-associated comorbidities such as hypertension, diabetes mellitus (DM), dyslipidemias, and gastroesophageal reflux disease (GERD).

Exclusion criteria

* Pregnant women. * Patients unfit for general anasthesia (ASA 4, 5) * Endocrine or psychiatric disorders. * History of previous upper abdmominal laparotomy. * Alcoholic addiction * Liver cirrhosis * Coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
percentage of excess weight lossat 12 months of follow-up\[preoperative weight - weight at 12 months\]/preoperative excess weight X 100

Secondary

MeasureTime frameDescription
Resolution of diabetes mellitusat 12 months of follow-upnumber of patients with fasting plasma glucose level \<110 mg/dL or HbA1C level \<6% without hypoglycemic medication

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026